학술논문

Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial
Document Type
Article
Author
Kambugu, AndrewKaimal, ArvindCastelnuovo, BarbaraKiiza, DanielAsienzo, JescaKisembo, JohnNsubuga, JohnOkwero, MaxMuyise, RhonaKityo, CissyNasaazi, ClaireNakiboneka, Dridah L.Mugerwa, HenryNamusanje, JosephineNajjuuko, TheresaMasaba, TimothySerumaga, TimothyAlinaitwe, AdolfArinda, AllanRweyora, AngelaAtegeka, GilbertKangah, Mary GorettiLugemwa, AbbasKasozi, MariamTukumushabe, PhionahAkunda, RogersMakumbi, ShaficMusumba, SharifMyalo, SulaAhuura, JohnNamusisi, Annet MaryKibirige, DanielKiweewa, FrancisMirembe, GraceMabonga, HabertWandege, JosephNakakeeto, JosephineNamubiru, SharonNansalire, WinfredSiika, Abraham MosigisiKwobah, Charles MejaMboya, Chris SandeMokaya, Martha Mokeira BisieriKaroney, Mercy JelagatCheruiyot, Priscilla ChepkorirCherutich, SalinahNjuguna, Simon WachiraKirui, Viola CherotichBorok, MargaretChidziva, EnnieMusoro, GodfreyHakim, JamesBhiri, JoylinePhiri, MisheckMudzingwa, ShepherdManyanga, TadiosKiragga, AgnesBanegura, Anchilla MaryHoppe, AnneBalyegisawa, ApoloAgwang, BettyIsaaya, BrianTumwine, ConstantineOdongpiny, Eva Laker A.Musaazi, JosephPaton, NicholasSenkungu, PeterWalimbwa, StephenKamara, YvonneAmperiize, MathiusAllen, ElizabethOpondo, CharlesMohammed, Perryvan Rein-van der Horst, WillemijnVan Delft, YvonBoateng, Fafa AddoNamara, DoreenKaleebu, PontianoOjoo, SylviaBwakura, TapiwanasheKatana, MillyVenter, FrancoisPhiri, SamWalker, SarahPaton, Nicholas ISiika, AbrahamOdongpiny, Eva Laker A
Source
In The Lancet HIV June 2022 9(6):e381-e393
Subject
Primary Research
Articles
Language
ISSN
2352-3018